David E. I. Pyott - 24 Jun 2024 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jun 2024, 16:28:27 UTC
Prior SEC filing
17 Jun 2024
Next SEC filing
25 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Brett Budzinski, Attorney-in-Fact For: David E.I. Pyott

Key filing fact

David E. I. Pyott filed Form 4 for ALNYLAM PHARMACEUTICALS, INC. (ALNY) on 26 Jun 2024.

Key facts

  • This page summarizes David E. I. Pyott's Form 4 filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
  • 9 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 26 Jun 2024, 16:28.

Change

  • Previous filing in this sequence was filed on 17 Jun 2024.
  • Current net transaction value: -$4,540,749.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALNY transaction

Common Stock

Options Exercise

Transaction value
$1,561,962
Shares
+17,560
Change %
+12912%
Price
$88.95
Shares after
17,696
Date
24 Jun 2024
Ownership
Direct
Footnotes
F1
ALNY transaction

Common Stock

Options Exercise

Transaction value
$520,884
Shares
+7,420
Change %
+42%
Price
$70.20
Shares after
25,116
Date
24 Jun 2024
Ownership
Direct
Footnotes
F1
ALNY transaction

Common Stock

Options Exercise

Transaction value
$537,765
Shares
+7,470
Change %
+30%
Price
$71.99
Shares after
32,586
Date
24 Jun 2024
Ownership
Direct
Footnotes
F1
ALNY transaction

Common Stock

Sale

Transaction value
$3,863,200
Shares
-17,560
Change %
-54%
Price
$220.00
Shares after
15,026
Date
24 Jun 2024
Ownership
Direct
Footnotes
F1
ALNY transaction

Common Stock

Sale

Transaction value
$1,639,820
Shares
-7,420
Change %
-49%
Price
$221.00
Shares after
7,606
Date
24 Jun 2024
Ownership
Direct
Footnotes
F1
ALNY transaction

Common Stock

Sale

Transaction value
$1,658,340
Shares
-7,470
Change %
-98%
Price
$222.00
Shares after
136
Date
24 Jun 2024
Ownership
Direct
Footnotes
F1
ALNY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
27,900
Date
24 Jun 2024
Ownership
by Trust
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-7,420
Change %
-66%
Price
$0.000000
Shares after
3,830
Date
24 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,420
Exercise price
$70.20
Footnotes
F1, F3
ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-7,470
Change %
-66%
Price
$0.000000
Shares after
3,780
Date
24 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,470
Exercise price
$71.99
Footnotes
F1, F4
ALNY transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-17,560
Change %
-70%
Price
$0.000000
Shares after
7,440
Date
24 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,560
Exercise price
$88.95
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023.

Footnote F2

The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.

Footnote F3

This stock option was fully vested and exercisable as of June 3, 2017.

Footnote F4

This stock option was fully vested and exercisable as of June 2, 2018.

Footnote F5

This stock option was fully vested and exercisable as of December 18, 2018.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .